𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis

✍ Scribed by Marcus B. Conde; José R. Lapa e Silva

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
101 KB
Volume
72
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meropenem–Clavulanate: A New Strategy fo
Meropenem–Clavulanate: A New Strategy for the Treatment of Tuberculosis?
✍ Ulrike Holzgrabe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract **The Great White Plague**: __Mycobacterium tuberculosis__, the bacteria causing tuberculosis, is a continuing threat to global health through the emergence of resistant strains and the lack of novel therapeutic agents. Recently reported results on this important work are highlighted.ma

Toxicity and preliminary results with a
Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas
✍ M. A. Fridrik; H. Hausmaninger; G. Michlmayr; R. Haidinger; H. L. Seewann; M. Le 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 1 views

A combination of two non-cross-resistant regimens, CEOP and IMVP-Dexa given every 4 weeks, three to six times according to response was tested in patients with untreated histological proven high and intermediate grade non-Hodgkin's lymphoma. To date eight Austrian centres entered 37 patients in thi

The social consequences for families wit
The social consequences for families with Alzheimer's disease patients: potential impact of new drug treatment
✍ Anders Wimo; Bengt Winblad; Margareta Grafstrom 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

The social consequences of Alzheimer's disease are highlighted in this review with regard to impact on family situation, a changing treatment context caused by demographic changes, reorganization of long-term care, a ®nancial crisis in the public health systems and the introduction of antidementia d

ChemInform Abstract: Darunavir (I), a Co
ChemInform Abstract: Darunavir (I), a Conceptually New HIV-1 Protease Inhibitor for the Treatment of Drug-Resistant HIV.
✍ Arun K. Ghosh; Zachary L. Dawson; Hiroaki Mitsuya 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 18 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

A dose-intensive, cyclophosphamide-based
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group
✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.